PHENERGAN VC W/ CODEINE
LOE Approachingcodeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride
NDAORALSYRUP
Approved
Jan 1952
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2m ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Phenergan VC with Codeine is a combination oral syrup containing codeine phosphate (opioid antitussive), phenylephrine hydrochloride (nasal decongestant), and promethazine hydrochloride (antihistamine/anticholinergic). It is indicated for symptomatic relief of cough and upper respiratory congestion associated with cold, allergy, or flu. The product works through multiple mechanisms: codeine suppresses cough via CNS action, phenylephrine reduces nasal congestion via alpha-1 adrenergic stimulation, and promethazine provides antihistamine and sedating effects.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating defensive commercial strategy and smaller brand team focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Phenergan VC with Codeine offers limited career growth and learning opportunities due to LOE Approaching status and flat commercial profile. Career development is best suited for professionals seeking defensive brand management, cost-containment expertise, or transition into emerging products within ANI's portfolio.
Field Sales RepresentativeBrand Manager
Worked on PHENERGAN VC W/ CODEINE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.